Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA's CDER seeks an Ultrasonic Package for the Buchi Mini Spray Dryer S-300 to enhance pharmaceutical manufacturing. This equipment must produce spray dried powders suitable for intranasal drug delivery, achieving particle sizes up to sixty microns. Interested parties should respond to this sources sought notice.
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300. Advanced pharmaceutical manufacturing is an innovative pharmaceutical manufacturing technology, which has the potential to enhance drug quality, improve the reliability and robustness of the manufacturing process and supply chain, and increase timely access to quality medicines for the American public. One of FDA’s research priorities is to explore advanced manufacturing techniques, including manufacturing of spray dried powder for intranasal drug delivery.
CDER requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300 that can be installed on Buchi mini spray dryer S-300 and B-290. The ultrasonic nozzle should be capable of producing spray dried powders with ideal particle size for intranasal drug delivery (to produce particles up to sixty (60) microns).
ULTRASONIC PACKAGE FOR BUCHI MINI SPRAY DRYER S-300 is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.